Realizing the promise of cancer predisposition genes
- PMID: 24429628
- PMCID: PMC4975511
- DOI: 10.1038/nature12981
Realizing the promise of cancer predisposition genes
Erratum in
- Nature. 2014 Jun 5;510(7503):176
Abstract
Genes in which germline mutations confer highly or moderately increased risks of cancer are called cancer predisposition genes. More than 100 of these genes have been identified, providing important scientific insights in many areas, particularly the mechanisms of cancer causation. Moreover, clinical utilization of cancer predisposition genes has had a substantial impact on diagnosis, optimized management and prevention of cancer. The recent transformative advances in DNA sequencing hold the promise of many more cancer predisposition gene discoveries, and greater and broader clinical applications. However, there is also considerable potential for incorrect inferences and inappropriate clinical applications. Realizing the promise of cancer predisposition genes for science and medicine will thus require careful navigation.
Figures



References
-
- Broca P. Trait, des tumeurs. 1866
-
- Boveri T. Zur frage der entstehung maligner tumoren. Gustav Fischer; 1914.
-
- Fung YK, et al. Structural evidence for the authenticity of the human retinoblastoma gene. Science. 1987;236:1657–1661. - PubMed
-
- Varghese JS, Easton DF. Genome-wide association studies in common cancers--what have we learnt? Curr Opin Genet Dev. 2010;20:201–209. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources